DrugDashboards

Market view

foscarbidopa/foslevodopa

2 marketed package NDCs · 2 active manufacturers

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for foscarbidopa/foslevodopa, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Mfr exited
    Patheon Manufacturing Services LLC · foscarbidopa/foslevodopa
  • Mfr entered
    Patheon Manufacturing Services LLC · foscarbidopa/foslevodopa
  • Mfr exited
    Patheon Manufacturing Services LLC · foscarbidopa/foslevodopa
  • Mfr entered
    Patheon Manufacturing Services LLC · foscarbidopa/foslevodopa

Common questions

Is Foscarbidopa/foslevodopa in shortage right now?
No. FDA does not currently list Foscarbidopa/foslevodopa in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Foscarbidopa/foslevodopa?
2 companies have marketed Foscarbidopa/foslevodopa in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.